These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 28147318

  • 41. Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian carcinoma.
    Cohen S, Mosig R, Moshier E, Pereira E, Rahaman J, Prasad-Hayes M, Halpert R, Billaud JN, Dottino P, Martignetti JA.
    Gynecol Oncol; 2014 Sep; 134(3):591-8. PubMed ID: 24995581
    [Abstract] [Full Text] [Related]

  • 42. Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer.
    Elattar A, Warburton KG, Mukhopadhyay A, Freer RM, Shaheen F, Cross P, Plummer ER, Robson CN, Edmondson RJ.
    Gynecol Oncol; 2012 Jan; 124(1):142-7. PubMed ID: 22001143
    [Abstract] [Full Text] [Related]

  • 43. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
    Petrillo M, Marchetti C, De Leo R, Musella A, Capoluongo E, Paris I, Benedetti Panici P, Scambia G, Fagotti A.
    Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
    [Abstract] [Full Text] [Related]

  • 44. Potential utility of pretreatment serum miRNAs for optimal treatment selection in advanced high-grade serous ovarian cancer.
    Uehara T, Matsuzaki J, Yoshida H, Ogawa Y, Miura J, Fujimiya H, Yamamoto Y, Kawauchi J, Takizawa S, Yonemori K, Sakamoto H, Kato K, Ishikawa M, Ochiya T.
    Jpn J Clin Oncol; 2024 Aug 14; 54(8):917-925. PubMed ID: 38651188
    [Abstract] [Full Text] [Related]

  • 45. Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer.
    Smith G, Ng MT, Shepherd L, Herrington CS, Gourley C, Ferguson MJ, Wolf CR.
    Br J Cancer; 2012 Oct 09; 107(8):1327-36. PubMed ID: 22990650
    [Abstract] [Full Text] [Related]

  • 46. Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma.
    Stringer-Reasor EM, Baker GM, Skor MN, Kocherginsky M, Lengyel E, Fleming GF, Conzen SD.
    Gynecol Oncol; 2015 Sep 09; 138(3):656-62. PubMed ID: 26115975
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    Karlan BY, Dering J, Walsh C, Orsulic S, Lester J, Anderson LA, Ginther CL, Fejzo M, Slamon D.
    Gynecol Oncol; 2014 Feb 09; 132(2):334-42. PubMed ID: 24368280
    [Abstract] [Full Text] [Related]

  • 51. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
    Zhang K, Wang W, Chen L, Liu Y, Hu J, Guo F, Tian W, Wang Y, Xue F.
    Oncol Rep; 2020 Sep 09; 44(3):909-926. PubMed ID: 32705213
    [Abstract] [Full Text] [Related]

  • 52. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC, Gynecologic Oncology Group.
    Cancer; 2008 May 15; 112(10):2202-10. PubMed ID: 18348296
    [Abstract] [Full Text] [Related]

  • 53. A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinoma.
    Sun CY, Su TF, Li N, Zhou B, Guo ES, Yang ZY, Liao J, Ding D, Xu Q, Lu H, Meng L, Wang SX, Zhou JF, Xing H, Weng DH, Ma D, Chen G.
    Oncotarget; 2016 Jan 19; 7(3):3245-54. PubMed ID: 26675546
    [Abstract] [Full Text] [Related]

  • 54. Prognostic impact of Apaf-1, Cyclin D1, and AQP-5 in serous ovarian carcinoma treated with the first-line chemotherapy.
    Abdelrahman AE, Fathy A, Elsebai EA, Nawar N, Etman WM.
    Ann Diagn Pathol; 2018 Aug 19; 35():27-37. PubMed ID: 30072015
    [Abstract] [Full Text] [Related]

  • 55. CLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancer.
    Ye Y, Yin M, Huang B, Wang Y, Li X, Lou G.
    Tumour Biol; 2015 Jun 19; 36(6):4175-9. PubMed ID: 25582317
    [Abstract] [Full Text] [Related]

  • 56. Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.
    Soyama H, Miyamoto M, Takano M, Aoyama T, Matsuura H, Sakamoto T, Takasaki K, Kuwahara M, Kato K, Yoshikawa T, Iwahashi H, Tsuda H, Furuya K.
    Med Oncol; 2017 Nov 22; 34(12):201. PubMed ID: 29168038
    [Abstract] [Full Text] [Related]

  • 57. Prognostic implications of histological tumor regression (Böhm's score) in patients receiving neoadjuvant chemotherapy for high grade serous tubal & ovarian carcinoma.
    Rajkumar S, Polson A, Nath R, Lane G, Sayasneh A, Jakes A, Begum S, Mehra G.
    Gynecol Oncol; 2018 Nov 22; 151(2):264-268. PubMed ID: 30197060
    [Abstract] [Full Text] [Related]

  • 58. Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer.
    Freimund AE, Beach JA, Christie EL, Bowtell DDL.
    Hematol Oncol Clin North Am; 2018 Dec 22; 32(6):983-996. PubMed ID: 30390769
    [Abstract] [Full Text] [Related]

  • 59. Expression of FOXP1 in epithelial ovarian cancer (EOC) and its correlation with chemotherapy resistance and prognosis.
    Hu Z, Zhu L, Gao J, Cai M, Tan M, Liu J, Lin B.
    Tumour Biol; 2015 Sep 22; 36(9):7269-75. PubMed ID: 25895457
    [Abstract] [Full Text] [Related]

  • 60. Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.
    Muraji M, Sudo T, Iwasaki S, Ueno S, Wakahashi S, Yamaguchi S, Fujiwara K, Nishimura R.
    Gynecol Oncol; 2013 Dec 22; 131(3):531-4. PubMed ID: 24096109
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.